Immediate Impact

32 standout
Sub-graph 1 of 14

Citing Papers

Interstitial Lung Disease
2024 Standout
Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies
2024 Standout
2 intermediate papers

Works of B. Camara being referenced

Killed but metabolically active Pseudomonas aeruginosa -based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections
2018
Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases
2010

Author Peers

Author Last Decade Papers Cites
B. Camara 108 82 15 39 28 242
Nihal Martis 68 35 23 57 24 245
Nilgün Karadağ 59 84 65 19 34 249
Mitsuo Obana 44 54 43 52 33 266
Katja Masjosthusmann 57 48 44 63 24 242
Salih Gözmen 46 28 21 17 42 286
Johanna H. Oudshoorn 62 66 79 61 16 283
Toshinobu Yokoyama 68 56 54 17 25 203
Bülent Ataş 65 43 37 54 36 293
Hugo Guillermo Ternavasio‐de la Vega 76 25 25 12 16 193
Tercan Us 100 28 20 20 31 281

All Works

Loading papers...

Rankless by CCL
2026